Baillie Gifford & Co’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $196K | Sell |
|
|||||
|
2024
Q2 | $754K | Sell |
|
|||||
|
2024
Q1 | $1.46M | Sell |
|
|||||
|
2023
Q4 | $1.34M | Sell |
|
|||||
|
2023
Q3 | $1.08M | Sell |
|
|||||
|
2023
Q2 | $2.42M | Hold |
|
|||||
|
2023
Q1 | $1.8M | Hold |
|
|||||
|
2022
Q4 | $2.64M | Buy |
|
|||||
|
2022
Q3 | $5.54M | Buy |
|
|||||
|
2022
Q2 | $4.62M | Sell |
|
|||||
|
2022
Q1 | $3.96M | Buy |
|
|||||
|
2021
Q4 | $5.6M | Buy |
|
|||||
|
2021
Q3 | $6.33M | Buy |
|
|||||
|
2021
Q2 | $4.2M | Buy |
|